2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Advanced CRC: Should Pembrolizumab Be The New SoC as First-line Therapy in Patients With MSI-H mCRC?

499 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login